Details for New Drug Application (NDA): 063329
✉ Email this page to a colleague
The generic ingredient in CLINDA-DERM is clindamycin phosphate. There are fifty-five drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the clindamycin phosphate profile page.
Summary for 063329
Tradename: | CLINDA-DERM |
Applicant: | Padagis Us |
Ingredient: | clindamycin phosphate |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;TOPICAL | Strength | EQ 1% BASE | ||||
Approval Date: | Sep 30, 1992 | TE: | AT | RLD: | No |
Complete Access Available with Subscription